Supplementary figure S2. from Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target

Distribution of patients by response status based on a restricted list of 41 transcripts present in our custom NanoString panel and in the list of transcripts of the first two studies which identified the MA sub-type (1) and the class A sub-type (2). Non-supervised Heatmap of genes discriminating molecular apocrine versus basal tumors in the Farmer et al. and Doane et al. papers, n=41 genes, and present in the Nanostring PanCancer pathway panel.